Gary Lauer
Analyst · Richard Fetyko from Janney Capital
Thanks, Kate, and good afternoon, everyone, and thanks for joining us as we review our third quarter 2012 results. During the quarter, we saw a further improvement in our Individual & Family plan business, highlighted by both membership and submitted application growth.
We continue to generate strong growth in Medicare product sales, and, importantly, we invested in and prepared for the Medicare Annual Enrollment Period, which kicked off last week.
Third quarter revenue was $37.6 million and GAAP earnings per share were $0.01, reflecting the Medicare-related investments we made during the quarter. EBITDA was $3.4 million and cash flow from operations was $6.9 million. At the end of the quarter, we had $131 million in cash on the balance sheet and no debt.
During the quarter, we announced a $30 million stock repurchase program. As a reminder, we have completed 3 stock repurchase programs over the past 4 years, spending $90 million to reduce our outstanding share count by over 20% since late 2008, when the first repurchase program was implemented.
We continue to believe that at the current share price levels, repurchasing our shares is a prudent use of our cash.
At this point, I'd like to make some comments about our Individual & Family plan business, an area in which we once again saw positive performance after 2 challenging years. Our third quarter Individual & Family plan submitted applications grew 5% year-over-year, accelerating from the 2% growth rate we generated in the second quarter of 2012. There was also a dramatic improvement -- this was, sorry, was a dramatic improvement compared to a 20% year-over-year decline in submitted applications in the third quarter of 2011.
In the third quarter, we resumed growth in revenue-generating Individual & Family plan members at a 2% year-over-year growth rate. It's important to note that we return the application and membership growth in the IFP business in a disciplined way, while continuing to improve our cost of acquisition per submitted Individual & Family plan member and ensuring that each acquisition channel remains profitable based on our current lifetime member value projections.
In fact, our acquisition cost per Individual & Family plan member has declined on a year-over-year basis every quarter since the second quarter of 2010. Based on the trends we are seeing in our Individual & Family plan business, we continue to expect positive submitted application growth for the full year 2012. We also believe that by early 2013, we will absorb the majority of the impact of last year's commission rate reductions, and given current course and speed, we expect to grow Individual & Family plan commission revenues in 2013.
Growth in next year's non-Medicare commission revenue is expected to be primarily driven by growth in our Individual & Family plan membership base, and also helped by our successful ancillary product strategy, including dental, vision, accident and other insurance products.
Finally, with respect to our Individual business, I'd like to note once again that if the Affordable Care Act is implemented, it's not without risk to eHealth. A lot remains to be done to prepare for the meaningful changes in the individual market anticipated in 2014.
In our Medicare business, we continue to see significant consumer demand outside of the Annual Enrollment Period. Third quarter Medicare revenue was $6.3 million, representing a 93% year-over-year growth rate. The number of total Medicare products sold during the quarter grew in excess of 110%, and the number of Medicare Advantage products sold grew in excess of 180% compared to the third quarter of 2011.
In this past third quarter, we signed a number of important partnership agreements that are expected to contribute to Medicare product sales during the Annual Enrollment Period, and have done a lot of work on search engine optimization on eHealth core competency to enhance natural ratings of our Medicare sites.
During the third quarter, we fulfilled in-house, as a broker, nearly 100% of Medicare demand that we generated compared to 53% in the third quarter of 2011. As a reminder, in-house fulfillment is characterized by significantly higher lifetime revenue values and margin dollars compared to the sale of Medicare leads. We were also more effective at converting demand into enrollments compared to the third quarter of 2011.
The Annual Enrollment Period for Medicare started last week on October 15, and will run through December 7. As a reminder, the majority of Medicare sales for the year occurred during this period.
We believe that we are well-positioned for this year's Annual Enrollment Period. Our inventory of Medicare products is broader this year compared to 2011. In addition to Medicare Advantage and Prescription Drug Plan products from Humana, Aetna, Anthem, and WellCare, we now offer products from CIGNA, CVS Caremark, Blue Cross Blue Shield of Michigan and Medica. We are also growing our presence in the Medicare Supplement market with products from Mutual of Omaha, Humana, Anthem and Primera, that are now available online.
As expected, in preparation for the Annual Enrollment Period, we meaningfully ramped our investment in our Medicare dedicated customer care resources, reflecting our successful transition to the in-house fulfillment model for Medicare demand. This is reflected in our operating expenses for the quarter, and Stuart will provide more color on this later during the call.
In conclusion, the last 2 years have certainly been challenging with many of the uncertainties of the Affordable Care Act relating to the Individual & Family plan business. At the same time, we've been investing aggressively to build our new Medicare business. I am pleased with our progress to date in both areas and believe that our financial results speak to this progress.
We have returned to growth in the Individual & Family plan submitted applications area and Individual & Family plan membership. We delivered strong growth in Medicare revenues and continue to generate meaningful cash flows from operations.
We will be providing guidance for the full year 2013 on our fourth quarter earnings call, which typically takes place in mid-February. At this point, I'd like to turn the call over to Stuart for more remarks on our financial progress. Stuart?